Revance Therapeutics, Inc. (RVNC) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Revance Therapeutics, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Investment Score:
69/100
Strong
Valuation Metrics
P/E Ratio
-2.30
Weak
WeakModerateStrong
P/B Ratio
-4.91
Weak
WeakModerateStrong
Earnings Yield
-43.57%
Weak
WeakModerateStrong
Profitability Health
Return on Equity
213.71%
Strong
WeakModerateStrong
Operating Margin
-135.35%
Weak
WeakModerateStrong
Net Profit Margin
-138.43%
Weak
WeakModerateStrong
Growth Indicators
Revenue Growth
76.55%
Strong
WeakModerateStrong
Net Income Growth
9.10%
Moderate
WeakModerateStrong
EPS Growth
21.84%
Strong
WeakModerateStrong
Efficiency & Liquidity
Current Ratio
3.80
Strong
WeakModerateStrong
Quick Ratio
3.29
Strong
WeakModerateStrong
Asset Turnover
0.49x
Weak
WeakModerateStrong
Inventory Turnover
3.34x
Weak
WeakModerateStrong